Duke Team Identifies a Strategy to Guide the Immune System to Respond to HIV
Experimental Flu Vaccines to be Made at Duke
The Duke Human Vaccine Institute has been awarded a $7 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), to manufacture H5N1 avian flu vaccines for use in cli
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design
A Duke University School of Medicine study in Molecular Cell provides the most detailed look yet at the SARS-CoV-2
DHVI Receives Contract to Manufacture Investigational Avian Flu Vaccines
The Duke Human Vaccine Institute received funding from the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health, to manufacture H5N1 avian fl
2024 William G. Anlyan Lifetime Achievement Award Barton F. Haynes, MD, HS’73-’75
Barton F. Haynes, MD, HS’73 -’75, is the Frederic M.
A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies
Scientists See an Ultra-Fast Movement in an HIV-1 Surface Protein
As the HIV virus glides up outside a human cell to dock and possibly inject its deadly cargo of genetic code, there’s a spectacularly brief moment in which a tiny piece of its surface snaps open to
